Stockscreener 앱 받기
24.80
5.17%
1.22
시간 외 거래:
24.43
-0.37
-1.49%
전일 마감가:
$23.58
열려 있는:
$24.19
하루 거래량:
2.83M
Relative Volume:
1.12
시가총액:
$3.17B
수익:
$642.82M
순이익/손실:
$-43.54M
주가수익비율:
-70.94
EPS:
-0.3496
순현금흐름:
$130.12M
1주 성능:
+13.66%
1개월 성능:
+31.99%
6개월 성능:
+114.90%
1년 성능:
+199.70%
1일 변동 폭
$23.95
$25.29
1주일 범위
$22.21
$25.29
52주 변동 폭
$7.25
$25.29
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
24.80 | 2.97B | 642.82M | -43.54M | 130.12M | -0.3496 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo
TXG (10x Genomics) Receipts from Customers - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
10X Genomics Hits New 52-Week High of $23.60, Reflecting Strong Growth - Markets Mojo
10X GENOMICS INC-CLASS A (TXG) Fundamental Analysis & Valuation - ChartMill
10x Genomics stock hits 52-week high at 23.6 USD By Investing.com - Investing.com Canada
10x Genomics, Inc. (TXG) Stock Price, News, Quote & History - Yahoo! Finance Canada
10x Genomics stock hits 52-week high at 23.6 USD - Investing.com
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance Singapore
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
10x Genomics Inc. (US88025U1097.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
William Blair upgrades 10x Genomics (TXG) - MSN
10x Genomics (TXG) Receives Upgrade to 'Outperform' by William B - GuruFocus
10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout10x Genomics (NASDAQ:TXG) - Benzinga
10x Genomics (NASDAQ:TXG) Shares Gap Up Following Analyst Upgrade - MarketBeat
10x Genomics (NASDAQ:TXG) Upgraded to Outperform at William Blair - MarketBeat
Inside 10x Genomics’ Mission to Measure Biology at Scale - SynBioBeta
JPMorgan Chase & Co. Raises Position in 10x Genomics $TXG - MarketBeat
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Yahoo Finance
10X Genomics Stock Hits Day Low of $15.90 Amid Price Pressure - Markets Mojo
10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus
10x Genomics (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Bioptimus launches spatial biology atlas with 10x Genomics By Investing.com - Investing.com Canada
10x genomics CEO Saxonov sells $288,908 in stock By Investing.com - Investing.com Australia
10x genomics CEO Saxonov sells $288,908 in stock - Investing.com UK
10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat
Serge Saxonov Sells 5,000 Shares of 10x Genomics (NASDAQ:TXG) Stock - MarketBeat
10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan
Vanguard realigns reporting; subsidiaries to report TXG holdings (TXG) - Stock Titan
Bioptimus launches spatial biology atlas with 10x Genomics - Investing.com
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs - The AI Journal
A new atlas aims to map 100,000 patient samples across 3 continents - Stock Titan
Vanguard amends 13G for 10X Genomics (NASDAQ: TXG) reporting 0 shares - Stock Titan
10x Genomics Undervalued Amid Consumables-Led Transition - National Today
10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG) - Seeking Alpha
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics - Investing.com
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics By Investing.com - Investing.com India
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool
10x Genomics Stock Analysis: Recent Gains vs. Long-Term Growth Challenges | 2026News and Statistics - IndexBox
10X Genomics Hits Day High with 8.39% Surge Amid Market Volatility - Markets Mojo
ARK Investment Increases Stake in 10x Genomics (TXG) with Major Purchase - gurufocus.com
Cathie Wood’s ARK adds 10x Genomics stock, trims Arcturus - Investing.com
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10X 제노믹스 주식 (TXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
Mar 24 '26 |
Sale |
19.52 |
5,000 |
97,612 |
1,172,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 02 '26 |
Sale |
22.73 |
16,152 |
367,097 |
1,203,667 |
2.51%
1.81%
자본화:
|
볼륨(24시간):